Strictly defined familial male breast cancer
Authors:
- 9 November 2010
- journal article
- case report
- Published by Springer Nature in Familial Cancer
- Vol. 10 (1) , 73-77
Abstract
The term "familial male breast cancer" is often misleading, because in the breast cancer families reported in the literature, the vast majority of the patients were women and only a few were men. In this report, we present the rare case of a strictly defined familial male breast cancer (MBC) in which exclusively men were diagnosed with breast cancer. Three of four brothers developed the disease between the age of 46 and 64 years within a period of 21 years whereas all female relatives remained unaffected. The three affected men did not show the typical known clinical and genetic risk factors for MBC. An X-linked recessive inheritance may be possible in these cases. One way to potentially improve the identification of the causes of MBC could be a through a strictly studying families in which the male members were exclusively diagnosed with this malignancy. This approach emphasizes familial MBC as a distinct entity and not only as a variant of female breast cancer.Keywords
This publication has 28 references indexed in Scilit:
- Male breast cancer: An update in diagnosis, treatment and molecular profilingMaturitas, 2010
- Multidisciplinary Meeting on Male Breast Cancer: Summary and Research RecommendationsJournal of Clinical Oncology, 2010
- The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer casesEuropean Journal of Human Genetics, 2010
- Examining Breast Cancer Growth and Lifestyle Risk Factors: Early Life, Childhood, and AdolescenceClinical Breast Cancer, 2008
- BRCA1/2 mutation analysis in male breast cancer families from North West EnglandFamilial Cancer, 2007
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- Male breast cancerThe Lancet, 2006
- CHEK2*1100delC and male breast cancer risk in IsraelInternational Journal of Cancer, 2003
- Role of CHEK2*1100delC in unselected series of non‐BRCA1/2 male breast cancersInternational Journal of Cancer, 2003
- CHEK2 1100delC is not a risk factor for male breast cancer populationInternational Journal of Cancer, 2003